Eustace Fernandes is a Respiratory physician affiliated with Community Health Systems - Lutheran Hospital. OpenAlex indexes 7 publications with 767 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7916 W Jefferson Blvd
Fort Wayne, IN 468044140
Telephone
260-432-2297Provider last certified this registry record 23 Sept 2020.
Clinical trials
- The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy
Sponsor: Lutheran Hospital, Indiana
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- INTUITIVE SURGICAL, INC.Program year20255 payments
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
52.5%Corticosteroid32.4%Trelegy Ellipta56%Breztri Aerosphere20%Breo Ellipta16%Fluticasone Propionate4%Dulera3%Budesonide-Formoterol Fumarate2%Part D<11 patientsbeta2-Adrenergic Agonist8.8%Albuterol Sulfate Hfa83%Ventolin Hfa17%Part D<11 patients+ 3 more classes in this area
Anti-infectives
17.3%Macrolide Antimicrobial12.2%Azithromycin100%Part D≥77 patientsFluoroquinolone Antibacterial1.2%Levofloxacin100%Part D≥16 patients+ 4 more classes in this area
Metabolism & gastrointestinal
14.9%Corticosteroid7.6%Prednisone100%Part D≥69 patientsH2 blocker2.9%Famotidine100%Part D≥17 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
American Journal of Respiratory and Critical Care Medicine
2022 - Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain
Annals of Tropical Paediatrics
2001
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”